You are currently browsing the archives for 21 June 2018.
Displaying 1 entry.

Cancer pain drug market to be $3.

Related StoriesViralytics enters into scientific trial collaboration agreement with MSDCornell biomedical engineers develop 'super organic killer cells' to destroy tumor cells in lymph nodesNew RNA check of blood platelets can be used to identify location of cancers’We anticipate that fast acting fentanyl reformulations will enjoy significant uptake in the breakthrough discomfort marketplace segment,’ said Decision Assets Analyst Janie Mackay, Ph.D. ‘However, specialists we interviewed indicate that physicians treating cancer pain tend to be reluctant to prescribe novel therapies because of strict adherence to the Globe Health Organization discomfort ladder which advocates the use of old analgesics such as morphine.